Back
SPDR S&P® North American Natural Res ETF Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
30
NANR
SPDR S&P® North American Natural Res ETF
Last Price:
56.10
Seasonality Move:
1.1%
Buy
56
LBPH
Longboard Pharmaceuticals
Last Price:
33.93
Seasonality Move:
-17.05%
Sell
30
SPDR S&P® North American Natural Res ETF (NANR)
is a Sell
Is SPDR S&P® North American Natural Res ETF a Buy, Sell or Hold?
- The current SPDR S&P® North American Natural Res ETF [NANR] share price is $56.05. The Score for NANR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NANR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $33.89. The Score for LBPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NANR Stock Price Chart
What is SPDR S&P® North American Natural Res ETF's stock price today?
-
The SPDR S&P® North American Natural Res ETF share price today is $56.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NANR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $33.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
NANR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 59.37 | Buy |
Chaikin Money Flow: | 16343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.93 - 56.23) | Buy |
Bollinger Bands (100): | (53.87 - 56.73) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 50.99 | Buy |
Chaikin Money Flow: | -590951 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.08 - 36.28) | Sell |
Bollinger Bands (100): | (21.09 - 35.99) | Buy |
NANR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.87 | Buy |
20-day SMA: | 54.99 | Buy |
50-day SMA: | 54.94 | Buy |
200-day SMA: | 53.23 | Buy |
8-day EMA: | 55.18 | Buy |
20-day EMA: | 54.89 | Buy |
50-day EMA: | 54.88 | Buy |
200-day EMA: | 53.98 | Buy |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.02 | Buy |
20-day SMA: | 33.9 | Sell |
50-day SMA: | 34.81 | Sell |
200-day SMA: | 23.39 | Buy |
8-day EMA: | 32.41 | Buy |
20-day EMA: | 33.31 | Buy |
50-day EMA: | 32.77 | Buy |
200-day EMA: | 24.23 | Buy |
SPDR S&P® North American Natural Res ETF Earnings Growth & NANR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
SPDR S&P® North American Natural Res ETF Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |